Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Bull Exp Biol Med ; 161(2): 218-20, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27383154

ABSTRACT

Single administration of the obestatin fragment 1-4 (300 nmol/kg) to male Wistar rats produced a significant weight loss in male rats on observation days 5-8, while in female rats only on day 8. In addition, males demonstrated decreased risk factor in the elevated plus-maze test, but no effect of the preparation on behavior of female rats was revealed. Obestatin fragment 1-4 had no effect on corticosterone level 1 week after single administration in both females and male rats.


Subject(s)
Anti-Obesity Agents/pharmacology , Oligopeptides/pharmacology , Animals , Corticosterone/blood , Female , Male , Maze Learning , Rats, Wistar , Risk-Taking , Stress, Psychological/blood
2.
Bull Exp Biol Med ; 159(1): 38-40, 2015 May.
Article in English | MEDLINE | ID: mdl-26033586

ABSTRACT

We studied the effects of anorectic peptide obestatin and its fragment (1-4) on the antioxidant defense system in animals with normal and experimentally induced increased body weight. In rats with normal body weight, no changes in activity of the antioxidant defense system 1 week after single administration of the substances. After chronic administration of obestatin and fragment (1-4) for 1 week, total antioxidant capacity of the plasma decreased; obestatin also lowered the content of TBA-reactive products. In the overweight rats, SOD-like activity in the plasma increased 1 week after chronic administration of obestatin. Hence, obestatin and its fragment (1-4) induced changes in the antioxidant defense system only after chronic administration.


Subject(s)
Antioxidants/analysis , Appetite Depressants/pharmacology , Overweight/drug therapy , Peptide Fragments/pharmacology , Peptide Hormones/pharmacology , Amino Acid Sequence , Animals , Appetite Depressants/administration & dosage , Appetite Depressants/therapeutic use , Catalase/blood , Diet, High-Fat/adverse effects , Drug Administration Schedule , Drug Evaluation, Preclinical , Male , Molecular Sequence Data , Overweight/blood , Overweight/etiology , Peptide Fragments/administration & dosage , Peptide Hormones/administration & dosage , Peptide Hormones/therapeutic use , Rats , Rats, Wistar , Superoxide Dismutase/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...